Industry News
Vitamin D testing
Scientists are reporting development of a much-needed reference material to ensure that measurements of vitamin D levels are accurate. [ + ]
US biosecurity board speaks out on H5N1 concerns
The US National Science Advisory Board for Biosecurity has explained in detail its rationale in requesting two papers dealing with highly pathogenic H5N1. [ + ]
Biosceptre develops targeted antibodies for cancer treatment
Biosceptre has announced that it is about to clinically trial the use of targeted antibodies as a method to treat cancer. At a Sydney conference held on 24 January, it was revealed that the company has identified a receptor found only in cancer cells. [ + ]
Immuron, Monash partner to develop colostrum therapy
Melbourne-based Immuron (ASX:IMC) and Monash University will collaborate on products aimed at treating C. difficile infections, using Immuron's colostrum technology. [ + ]
Ascent sold to Watson for $375m
Indian pharmaceutical company Strides Arcolab has sold its Australian generic pharmaceutical manufacturer Ascent Pharmahealth to Watson Pharmaceutical. [ + ]
Mesoblast shares up following FDA tick for phase II trials
The US Food and Drug Administration has given the go-ahead for Mesoblast (ASX:MSB) to conduct phase II trials of its stem cell treatment for Type 2 diabetes. [ + ]
Nominations for PM’s Prizes for Science open
The Prime Minister’s Prizes for Science are now open for nomination, including the $50,000 Science Minister’s Prize for Life Scientist of the Year. [ + ]
Last chance to take part in AusBiotech’s annual CEO survey
With the annual CEO Industry Position Survey 2012 closing this week, AusBiotech urges industry leaders to take this opportunity to contribute to the research, enabling an updated and comprehensive view of the Australian biotechnology sector. [ + ]
Cosmo Bio appoints Australian distributor
Cosmo Bio has appointed United Bioresearch as its Australian distributor. [ + ]
Waters recognises Thomson MS Laboratory as Center of Innovation
Waters Corporation has recognised the Thomson Mass Spectrometry Laboratory at the University of Campinas (UNICAMP), Brazil, as a Waters Center of Innovation. [ + ]
Australian-French partnership team up for drug development
The Monash Institute of Pharmaceutical Sciences and France's Servier have entered a three-year partnership for drug development research into G Protein-Coupled Receptors. [ + ]
Pumping iron raises prospect Parkinson’s and Alzheimer's treatment
Researchers have found a drug that removes excess iron from the brain can prevent Parkinson’s and Alzheimer's disease in mice, raising the prospect of a new treatment. [ + ]
A promise to a dying friend turns to a quest for a cure
It began with a promise to a dying friend and became a dedicated quest for a cure for cancer ... and a fundraiser to help. [ + ]
Xenome raises soothing $8m for pain treatment trial
Brisbane-based biopharma Xenome Limited has secured $8m in funding from its major investors to pay for a clinical trial of a synthetic peptide as a pain inhibitor. [ + ]
Australian nuclear security ranked best in the world
Australia has the best nuclear materials security practices in the world according to the Nuclear Materials Security Index - a report released by the Nuclear Threat Initiative. [ + ]
